this lead up really is almost identical to the lead up to phase 3 results for NEU (which I also hold). It was hovering around the $2 mark for weeks before the phase 3 results date (the date when the results would be unveiled had already been released to the market) - and of course following the announcement of Phase 3 results the share price jumped 100% in a day. Then it was a similar story for FDA approval (the SP had climbed to around $7 immediately before the FDA announcement) and has then again doubled over the past 8 weeks.
General Investor Information EBR Systems, page-46
-
- There are more pages in this discussion • 231 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EBR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.02 |
Change
0.025(2.53%) |
Mkt cap ! $312.7M | |||
| Open | High | Low | Value | Volume |
| $1.00 | $1.06 | $1.00 | $100.2K | 96.64K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 980 | $1.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.08 | 3180 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| EBR (ASX) Chart |